Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octaplex vs Frozen Plasma in Bleeding Cardiac Surgery Patients
NCT05523297Phase 3Completed
- Sponsor
- Octapharma
- Start
- Nov 2022
- Primary completion
- Jun 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of balfaxar in hemorrhage, coagulation factor deficiency, sponsored by Octapharma. Started Nov 2022; status: completed.
02
Drugs
balfaxar
03
Conditions
hemorrhagecoagulation factor deficiency
Beyond the preview
Go deeper on NCT05523297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05523297.